# Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

> **NCT02732860** · — · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 120 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Colorectal Cancer
- Breast Cancer
- Breast Neoplasms
- Ovarian Cancer
- Ovarian Neoplasm

## Interventions

- **OTHER:** Molecular Profiling & In Vivo drug testing in pPDX and organoid cultures

## Key facts

- **NCT ID:** NCT02732860
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-12
- **Primary completion:** 2027-01-04
- **Final completion:** 2027-01-04
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02732860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02732860, "Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02732860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*